(Q41267885)

28 September 2017

1 reference

title

The role of theophylline in the management of chronic asthma in adults (English)

1 reference

28 September 2017

1 reference

2

Holgate ST

1 reference

28 September 2017

McDonald CJ

1

1 reference

28 September 2017

publication date

1 March 1996

1 reference

Clinical & Experimental Allergy

28 September 2017

published in

1 reference

28 September 2017

volume

26 Suppl 2

1 reference

28 September 2017

page(s)

42-46

1 reference

Cyclic AMP-dependent regulation of lipid mediators in white cells. A unifying concept for explaining the efficacy of theophylline in asthma

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Inhibitory effects of the anti-rat T-cell receptor (TCR) monoclonal antibody (MAb) R73 on various experimental autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: effect of anti-asthma drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

The effect of theophylline and enprofylline on allergen-induced bronchoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Regular inhaled beta-agonist treatment in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Tolerance with beta 2-adrenoceptor agonists: time for reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Clinical pharmacology of corticosteroids in bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

How much theophylline is enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Theophylline in the management of asthma: time for reappraisal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Compliance with prescribed drug therapy in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Reduced responsiveness of adenylate cyclase in alveolar macrophages from patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Theophylline suppresses human alveolar macrophage respiratory burst through phosphodiesterase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

The effect of theophyllamine on T-lymphocyte activation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Modulation of cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Theophylline--an immunomodulatory role in asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Anti-inflammatory effects of low-dose oral theophylline in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Inhibiton of the colony-forming capacity of human T-lymphocytes exerted by theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Regular inhaled salbutamol and airway responsiveness to allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Is the routine use of inhaled beta-adrenergic agonists appropriate in asthma treatment? No

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01143.X

10.1111/J.1365-2222.1996.TB01143.X

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference